SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+29.99%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$618M
AUM Growth
+$618M
(+15%)
Cap. Flow
-$43.5M
Cap. Flow
% of AUM
-7.05%
Top 10 Holdings %
Top 10 Hldgs %
30.62%
Holding
114
New
21
Increased
23
Reduced
33
Closed
17
Top Buys
| 1 |
Perspective Therapeutics
CATX
|
$14.8M |
| 2 |
CYBN
Cybin
CYBN
|
$10.6M |
| 3 |
BridgeBio Pharma
BBIO
|
$9.39M |
| 4 |
SentinelOne
S
|
$7.86M |
| 5 |
Outlook Therapeutics
OTLK
|
$6.82M |
Top Sells
| 1 |
Nova
NVMI
|
$17.2M |
| 2 |
Astria Therapeutics
ATXS
|
$14.6M |
| 3 |
Cartesian Therapeutics
RNAC
|
$14.2M |
| 4 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$13.6M |
| 5 |
Tower Semiconductor
TSEM
|
$11.7M |
Sector Composition
| 1 | Healthcare | 75.14% |
| 2 | Technology | 18.02% |
| 3 | Communication Services | 3.09% |
| 4 | Consumer Discretionary | 2.82% |
| 5 | Utilities | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Apogee Therapeutics
APGE
$2.17B
| – | – | -30,000 | Closed | -$838K |
|
102
Arrowhead Research
ARWR
$3.05B
| – | – | -144,899 | Closed | -$4.43M |
|
103
Cogent Biosciences
COGT
$1.69B
| – | – | -259,201 | Closed | -$1.52M |
|
104
Gilead Sciences
GILD
$140B
| – | – | -20,000 | Closed | -$1.62M |
|
105
Monte Rosa Therapeutics
GLUE
$296M
| – | – | -48,511 | Closed | -$274K |
|
106
Insmed
INSM
$28.8B
| – | – | 0 | – | – |
|
107
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – | -27,767 | Closed | -$6.42M |
|
108
MediWound
MDWD
$182M
| – | – | -48,980 | Closed | -$498K |
|
109
Oric Pharmaceuticals
ORIC
$994M
| – | – | -126,800 | Closed | -$1.17M |
|
110
Palo Alto Networks
PANW
$127B
| – | – | -16,585 | Closed | -$4.89M |
|
111
Prothena Corp
PRTA
$441M
| – | – | 0 | – | – |
|
112
PTC Therapeutics
PTCT
$3.92B
| – | – | -136,525 | Closed | -$3.76M |
|
113
Replimune Group
REPL
$422M
| – | – | -16,096 | Closed | -$136K |
|
114
Rigel Pharmaceuticals
RIGL
$697M
| – | – | -1,228,126 | Closed | -$1.78M |
|